cardio-protective therapy (CPT)

Figure 1: Taken from Chen et al (2020). Incidence of clinically driven target lesion revascularisation (TLR), target vessel myocardial infarction (TVMI), and target lesion failure (TLF). The table shows the hazard ratio and 95% confidence interval for TLR, TVMI, and TLF in the two-stent vs provisional stent group.

Latest News Other Categories Research & Trials

In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)

CardioNewsUK 17 August 2021 anthracyclines cardio-protective therapy (CPT)cardiotoxic chemotherapy chemotherapy-related cardiac dysfunction (CTCRD)COVID-19 DEFINITION II dexamethasone global longitudinal strain (GLS)Ischaemia Ischemia-CKD LoDoCo2 SUCCOUR

One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For those that were unable to attend, or for the sake of refreshing one’s memory, the following is a summary of all the trials presented…

BCS Heartbeat

FREE

VIEW